• Home
  • Market
  • Top 11 Stocks to Watch Today: Wipro, Infosys, Paytm, UltraTech Cement, and More!
Top 3 Auto Stocks to Buy Now: Uncovering Hidden Bargains in the Market

Top 11 Stocks to Watch Today: Wipro, Infosys, Paytm, UltraTech Cement, and More!

On April 16, Indian stock markets closed on a high note, with the Sensex gaining 309.40 points to finish at 77,044.29, while the Nifty advanced 108.65 points to reach 23,437.20. As the earnings season heats up and significant corporate updates unfold, investors are keenly focused on certain stocks today, April 17.

Key Stocks to Monitor on April 17, 2025

Wipro

Wipro has reported an impressive 25.9% year-on-year increase in its net profit, totaling Rs 3,569.6 crore for the March quarter. However, the outlook is less optimistic, as the IT giant cautioned that its IT services revenue might see a decline of up to 3.5% in the upcoming June quarter, citing global uncertainties. The company’s revenue for Q4 saw only a modest 1.3% rise to Rs 22,504.2 crore, reflective of a challenging global tech landscape.

Infosys

Today, Infosys is set to unveil its quarterly earnings, and investors are eagerly anticipating a potential dividend announcement. The company’s board is expected to decide on the payout and set the record date alongside the Q4 results, which could significantly impact market sentiment.

DLF

Real estate heavyweight DLF has secured a master framework agreement with Srijan Realty to divest its IT/ITeS SEZ project located in Kolkata. This Rs 693 crore transaction encompasses 25.9 acres of freehold land and the DLF Tech Park building, which boasts 10.54 lakh sq ft of leasable space. Structured as a slump sale, this deal is poised to enhance DLF’s cash flow.

Paytm

The stock of Paytm is under scrutiny after its founder and CEO, Vijay Shekhar Sharma, voluntarily relinquished 2.1 crore stock options granted under the 2019 ESOP plan. This decision results in a one-time non-cash expense of Rs 492 crore in Q4, drawing attention from investors amid regulatory scrutiny.

See also  Challenges Ahead for Infosys, Wipro, and TCS: US Client Spending Slashes Expected in FY26

Tata Steel

In a pioneering move, Tata Steel Nederland has partnered with the Port of Amsterdam, Ecolog, and other collaborators to establish the world’s first commercial-scale green hydrogen import corridor, linking Oman to Europe. This innovation underscores Tata Steel’s commitment to sustainable energy solutions.

Lupin

In a legal development affecting Lupin, a US court has upheld Astellas Pharma’s patent on Myrbetriq, a medication Lupin aims to produce a generic version of. The infringement trial has been postponed to 2026, providing Lupin some breathing room, although the company insists it has a robust case and is considering further legal avenues.

UltraTech Cement

UltraTech Cement has announced its intention to acquire a 26% stake in AMPIN C&I Power Eight, a venture focused on renewable energy. This strategic acquisition aligns with UltraTech’s goals of fulfilling its green energy requirements and meeting regulations for captive power consumption.

BHEL

BHEL has recently entered a technology transfer agreement with BARC aimed at developing indigenous hydrogen electrolysers utilizing membrane diaphragm technology. This initiative not only supports India’s ambitions for self-reliance in green hydrogen production but also enhances BHEL’s presence in the clean technology sector.

IRFC

The Madras High Court has delivered a favorable ruling for IRFC, overturning a tax demand of Rs 230.55 crore raised by the Assistant Commissioner (ST). This legal victory alleviates a significant burden for the public sector NBFC and offers regulatory relief.

Dalmia Bharat

In a concerning development, the Enforcement Directorate has provisionally attached land worth Rs 793.34 crore belonging to Dalmia Cement. This action is related to a 2011 CBI case concerning investments in Bharathi Cement. As the case remains unresolved, the ED’s decision raises new concerns for the company.

See also  Infosys Q4 Results Live: Anticipated Profit Dip, Flat Revenue, and Key FY26 Guidance Insights!

Glenmark Pharma

Glenmark Pharmaceuticals is gearing up to launch its generic version of Adderall in the US by May 2025. This product, used for treating ADHD, will be available in five different strengths and is bioequivalent to the original medication from Teva. The launch is expected to bolster Glenmark’s performance in the US market significantly.

Earnings Reports on the Horizon

A new wave of earnings reports is anticipated today, with industry giants like Infosys, HDFC Life Insurance, HDFC Asset Management, Jio Financial Services, and Tata Elxsi revealing their quarterly results. Other firms such as Mahindra EPC Irrigation, Indosolar, and National Standard (India) will also provide their financial updates, making today a pivotal day for investors.

Related Post

NIIT Set to Boost Holdings: Acquires 1.9 Million Shares of IFBI from ICICI Bank
NIIT Set to Boost Holdings: Acquires 1.9 Million Shares of IFBI from ICICI Bank
ByAbhinandanApr 19, 2025

NIIT Limited is set to acquire 1.9 million shares of IFBI from ICICI Bank, representing…

Next Week's Market Moves: Expert Trading Strategies and Key Technical Insights for Nifty and Sensex on D-Street
Next Week’s Market Moves: Expert Trading Strategies and Key Technical Insights for Nifty and Sensex on D-Street
ByAbhinandanApr 19, 2025

The Indian stock market is experiencing significant activity, with the Nifty 50 rising 1.8% to…

Global Economic Trends: ECB Rate Cuts vs. Canada's Steady Stance
Global Economic Trends: ECB Rate Cuts vs. Canada’s Steady Stance
ByAbhinandanApr 19, 2025

The global economic landscape is increasingly complex as central banks navigate trade tensions. The European…

Navigating Trump Tariffs: A 5-Step Guide to Rebalancing Your Portfolio from Stocks to Bonds for Optimal Risk Management
Navigating Trump Tariffs: A 5-Step Guide to Rebalancing Your Portfolio from Stocks to Bonds for Optimal Risk Management
ByAbhinandanApr 19, 2025

Effective investment portfolio management requires rebalancing, which realigns asset allocation with your initial strategy. This…

Leave a Reply

Your email address will not be published. Required fields are marked *

JOIN US

Get Newsletter

Subscribe our newsletter to get the best stories into your inbox!